Sundance Diagnostics

Sundance Diagnostics develops genetic safety tests that predict a patient’s risk of antidepressant-induced suicidal thinking and behavior.

Sundance Diagnostics is working to develop the world's first genetic safety tests to predict a patient’s risk of antidepressant-induced suicidal thinking or behavior. There is a strong need to make pharmaceutical drugs safer for patients—especially when those drugs have serious side effects and are being sold to millions of people. Sundance is using the most advanced genetic technologies to develop its safety tests to predict a patient’s risk. The goal is to save lives, improve treatment, increase patient confidence in treatment, and reduce the cost of treatment.